Mojca Jongen‐Lavrencic
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Hematology 48
- Acute Myeloid Leukemia Research 39
- Hematopoietic Stem Cell Transplantation 6
- Multiple Myeloma Research and Treatments 5
-
- RNA Interference and Gene Delivery 6
- Co-authors
- Bob Löwenberg (22 shared papers)Su Ming Sun (9 shared papers)Peter J.M. Valk (11 shared papers)M K Dijkstra (6 shared papers)Gert J. Ossenkoppele (17 shared papers)Pieter Sonneveld (11 shared papers)Bart J. Biemond (7 shared papers)Marinus van Marwijk Kooy (6 shared papers)
- Journals
- Blood (21 papers)Leukemia (7 papers)Journal of Clinical Oncology (4 papers)Leukemia Research (3 papers)Annals of the Rheumatic Diseases (2 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Mojca Jongen‐Lavrencic
68 papers receiving 3.1k citations
Mojca Jongen‐Lavrencic's Hit Papers
Peers
Comparison fields: 5 of 98
- Hematology 1.6k
- Cancer Research 759
- Genetics 349
- Molecular Biology 1.4k
- Oncology 470
Countries citing papers authored by Mojca Jongen‐Lavrencic
This map shows the geographic impact of Mojca Jongen‐Lavrencic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mojca Jongen‐Lavrencic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mojca Jongen‐Lavrencic more than expected).
Fields of papers citing papers by Mojca Jongen‐Lavrencic
This network shows the impact of papers produced by Mojca Jongen‐Lavrencic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mojca Jongen‐Lavrencic. The network helps show where Mojca Jongen‐Lavrencic may publish in the future.
Co-authors
The 25 scholars most cited alongside Mojca Jongen‐Lavrencic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia Hit paper breakdown → | 2009 | 596 |
| 2 | 2008 | 321 | |
| 3 | 2013 | 259 | |
| 4 | Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome Hit paper breakdown → | 2022 | 167 |
| 5 | 2019 | 119 | |
| 6 | 2011 | 117 | |
| 7 | 2011 | 99 | |
| 8 | 2008 | 92 | |
| 9 | 2018 | 86 | |
| 10 | 2020 | 81 | |
| 11 | 2022 | 77 | |
| 12 | 2017 | 66 | |
| 13 | 2018 | 64 | |
| 14 | 1996 | 59 | |
| 15 | 2015 | 58 | |
| 16 | Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease. | 1997 | 57 |
| 17 | 1996 | 55 | |
| 18 | 2009 | 52 | |
| 19 | 2018 | 51 | |
| 20 | 2012 | 48 |
About Mojca Jongen‐Lavrencic
Mojca Jongen‐Lavrencic is a scholar working on Hematology, Molecular Biology, Cancer Research, Genetics and Oncology, having authored 70 papers that have together received 3.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (39 papers), MicroRNA in disease regulation (12 papers), CAR-T cell therapy research (7 papers), Hematopoietic Stem Cell Transplantation (6 papers), RNA Interference and Gene Delivery (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Multiple Myeloma Research and Treatments (5 papers). The work is most often cited by research in Hematology (1.6k citations), Cancer Research (759 citations), Genetics (349 citations), Molecular Biology (1.4k citations) and Oncology (470 citations). Mojca Jongen‐Lavrencic has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Bob Löwenberg, Su Ming Sun, Peter J.M. Valk, M K Dijkstra, Gert J. Ossenkoppele, Pieter Sonneveld, Bart J. Biemond, Marinus van Marwijk Kooy, Gerard Vreugdenhil and Hartmut Döhner. Their work appears in journals such as Blood, Leukemia, Journal of Clinical Oncology, Leukemia Research and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.